
- Oncology NEWS International Vol 11 No 1
- Volume 11
- Issue 1
ACCC Launches New Public Policy Website
ROCKVILLE, Maryland-The Association of Community Cancer Centers (ACCC) has launched a new website (www.accc-cancer.org/publicpolicy) dedicated to regulatory and legislative issues affecting patients with cancer. The website will assist in the education of patients and their families about public policy that affects cancer care.
ROCKVILLE, MarylandThe Association of Community Cancer Centers (ACCC) has launched a new website (
The new website also was designed to serve as a tool to bring patients and physicians together to discuss important cancer issues, such as new therapeutic modalities, insurance reimbursement, and clinical trials. The public policy site features information for patients and their families regarding access to cancer care, and details on oral cancer drugs and the congressional actions affecting use of such drugs.
The site features a section on legislative alerts, general information about Capitol Hill legislators, and tips for patients with cancer and their families on communicating with their representatives. The site also provides a directory of ACCC member hospitals and physicians, a list of patient advocacy organizations, and contact information for representatives and senators.
"By providing patients and families with information about the public policies that impact cancer care and helping them learn about the legislative process, they will be able to fully act on their rights and enlist the government in their personal battles against cancer," said Margaret A. Riley, MN, RN, of ACCC’s Ad Hoc Committee for Advocacy.
Articles in this issue
over 23 years ago
ODAC Sends Mixed Message on New Gliadel Wafer Indicationalmost 24 years ago
ONCC Certification Test Results Are Announcedalmost 24 years ago
Rituximab Ups Survival in Aggressive and Indolent NHLalmost 24 years ago
Topotecan Used in Aggressive Front-Line Therapy for SCLCalmost 24 years ago
Depsipeptide Shows Activity in T-Cell Lymphomaalmost 24 years ago
FDG-PET Useful in Newly Diagnosed and Recurrent NSCLCalmost 24 years ago
Adjuvant Anastrozole Superior to Tamoxifen in Huge ATAC Breast Cancer Trialalmost 24 years ago
ODAC Backs Adding HER-2 DNA Test to Herceptin Package Insertalmost 24 years ago
FDA and VA Plan Joint AIDS Studyalmost 24 years ago
Breast Conservation Increases With On-Site Radiation UnitNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.